Heart Transplant Current Events | Heart Transplant News | 6
|
| Page
6 of
72 |
1429 Results |
|
|
|
Sort By:
Page Views | Date |
Switching immunosuppressants reduces cancer risk in kidney
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. view more (2009-11-02)
UT Southwestern patient first in North Texas to receive newest-generation heart failure device
UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant. view more (2009-10-27)
New protocol streamlines therapy that makes more kidney transplants possible
A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine. view more (2008-07-17)
Cancer drug effectively treats transplant rejections
University of Cincinnati (UC) researchers have discovered a new therapy for transplant patients, targeting the antibody-producing plasma cells that can cause organ rejection. view more (2008-12-29)
Blood Stem Cell Transplantation and Autoimmune Diseases
Study of Lupus Patient Confirms Promise of Stem Cell Transplant Therapy view more (2002-05-30)
Stem cell transplant can grow new immune system in certain mice, Stanford researchers find
Researchers at the Stanford University School of Medicine have taken a small but significant step, in mouse studies, toward the goal of transplanting adult stem cells to create a new immune system for people with autoimmune or genetic blood diseases. view more (2007-11-26)
Older patients with 1 type of heart failure may receive little or no benefit from drugs
People over 80 years of age suffering from a certain type of heart failure do not appear to benefit from most commonly prescribed heart medications, according to a study conducted at the Cedars-Sinai Heart Institute and published in the March 15 issue of The American Journal of Cardiology. view more (2009-03-12)
Protein level predicts who will develop deadly complication after marrow transplant
Researchers could determine one week after a bone marrow transplant which patients were likely to develop a serious and deadly complication, making them candidates for preventive treatment before any symptoms occur. view more (2006-02-17)
Researchers identify genes associated with lung transplant rejection
Researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco (UCSF) have identified six genes associated with lymphocytic bronchitis, which is thought to lead to obliterative bronchitis (OB), the most common cause of long-term failure of transplanted lungs. view more (2005-07-14)
Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients. view more (2008-06-20)
Alcohol may amplify chronic rejection in lung transplants
A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation. view more (2007-11-28)
Possible Hepatitis C vaccine
Hepatitis C Virus (HCV) infects up to 500,000 people in the UK alone, many of the infections going undiagnosed. It is the single biggest cause of people requiring a liver transplant in Britain. view more (2007-09-06)
Embryonic stem cells might help reduce transplantation rejection
Researchers have shown that immune-defense cells influenced by embryonic stem cell-derived cells can help prevent the rejection of hearts transplanted into mice, all without the use of immunosuppressive drugs. view more (2008-09-16)
1 patient's account of becoming a live kidney donor
Annabel Ferriman, an editor at the BMJ, gives a frank first person account of her journey through the "protracted" and sometimes "frustrating" process of becoming a live kidney donor to her friend, Ray, who had been suffering from polycystic kidney disease for eight years. view more (2008-06-16)
Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. view more (2008-08-19)
Obese patients wait longer for kidney transplants, research suggests
New research from Johns Hopkins specialists suggests that obese kidney disease patients face not only the usual long odds of a tissue match and organ rejection, but also are significantly less likely than normal-weight people to receive a kidney transplant at all. view more (2007-12-20)
Children's Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells
Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue. view more (2008-11-26)
How to identify early graft dysfunction preoperatively?
Small-for-size graft dysfunction (SFSGD) following living-related liver transplantation (LRLT) is characterized by early graft dysfunction (EGD) when the graft-to-recipient body weight ratio (GRBWR) is below 0.8%. view more (2009-10-16)
First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure. view more (2008-11-18)
ESC Congress 2004: Brazilian Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation in end-stage heart failure due to coronary disease
Cardiovascular disease remains the leading cause of morbidity and mortality around the world and patients with end-stage ischemic heart failure carry the highest morbid-mortality rate. Although heart transplant improves the outcomes of selected patients, the donor heart availability has limited its widespread utilization. Autologous bone marrow... view more... (2004-08-30)
|
|
| Page
6 of
72 |
1429 Results |
|
|
|
Sort By:
Page Views | Date |
|
